NMPA Approval

Clindamycin Phosphate for Injection

Approval Number

国药准字H20093563

Company四川宏明博思药业有限公司

Registration Date

January 10, 2024

Drug Information

Generic Name

注射用克林霉素磷酸酯

Dosage Form

注射剂

Strength

按C18H33ClN2O5S计:0.3g

Drug Type

化学药品

Registration Date

January 10, 2024

Company Information

Applicant Company

Company Name四川宏明博思药业有限公司

Company Address

成都高新区合作路343号

Manufacturing Company

Company Name四川宏明博思药业有限公司

Company Address

成都高新区合作路343号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.